Price T Rowe Associates Inc Lipocine Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.3 - $0.58 $3,018 - $5,835
-10,062 Reduced 5.45%
174,600 $56,000
Q4 2021

Feb 14, 2022
BUY
$0.99 - $1.2 $4,750 - $5,757
4,798 Added 2.67%
184,662 $183,000
Q3 2021

Nov 15, 2021
BUY
$1.08 - $1.49 $97,848 - $134,994
90,600 Added 101.5%
179,864 $196,000
Q1 2021

May 17, 2021
BUY
$1.38 - $2.28 $123,184 - $203,521
89,264 New
89,264 $135,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $394M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email